Effect of a 630 nm light on vasculogenic mimicry in A549 lung adenocarcinoma cells in vitro

Photodiagnosis Photodyn Ther. 2023 Dec:44:103831. doi: 10.1016/j.pdpdt.2023.103831. Epub 2023 Oct 6.

Abstract

Objective: The objective of this study was to investigate the effect of photodynamic therapy (PDT) on the formation of vasculogenic mimicry (VM) in the human lung adenocarcinoma A549 cell line in vitro.

Methods: The participants were divided into a blank control group, a photosensitizer group, a light group, and a PDT group. Cells from each group were cultured in three dimensions using Matrigel, and vasculogenic mimicry generation was observed microscopically. Periodic Acid-Schiff (PAS) staining was used to verify the vasculogenic mimicry structure. Reverse Transcription-Polymerase Chain Reaction (RT-PCR) was used to detect the expression levels of cellular osteopontin (OPN) and vascular endothelial growth factor (VEGF) mRNA. Western blotting was used to detect the expression levels of cellular OPN and VEGF protein.

Results: A549 cells cultured on Matrigel for about six hours revealed VM on PAS staining, and the number of formations was significantly reduced in the PDT group compared with other groups (P < 0.05). The RT-PCR results showed that the PDT group downregulated OPN and VEGF mRNA expression compared with each control group (P < 0.05). Western blot results showed that OPN and VEGF protein expression was downregulated in the PDT group compared with each control group (P < 0.05). The results of RT-PCR showed that the expression of OPN and VEGF mRNA was downregulated in the PDT group compared with each control group (P < 0.05). The results of Western blotting showed that the expression of OPN and VEGF was downregulated in the protein PDT group compared with each control group (P < 0.001).

Conclusion: Photodynamic therapy significantly inhibited the formation of vasculogenic mimicry in human lung adenocarcinoma A549 cells in vitro and downregulated the expression of OPN, VEGF mRNA, and protein levels.

Keywords: Lung carcinoma; Osteopontin; Photodynamic therapy; Vascular endothelial growth factor; Vasculogenic mimicry.

MeSH terms

  • A549 Cells
  • Adenocarcinoma of Lung* / drug therapy
  • Humans
  • Lung Neoplasms* / drug therapy
  • Neovascularization, Pathologic / pathology
  • Photochemotherapy* / methods
  • Photosensitizing Agents / pharmacology
  • RNA, Messenger / metabolism
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Vascular Endothelial Growth Factor A
  • Photosensitizing Agents
  • RNA, Messenger